| Name: | KalVista Pharmaceuticals, Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 12 Nov 2024 (2 months ago) |
| Entity Number: | 10291042 |
| Place of Formation: | DELAWARE |
| Address: | 55 CAMBRIDGE PARKWAY, SUITE 901E, CAMBRIDGE, MA 02142 |
| Name | Role |
|---|---|
| Benjamin Palleiko | Director |
| Brian Pereira | Director |
| Patrick Treanor | Director |
| BlackRock Institutional Trust Company, N.A. | Shareholder |
| Frazier Life Sciences Management, L.P. | Shareholder |
| Benjamin Palleiko | President |
| Benjamin Palleiko | Secretary |
| Nancy Stewart | Director |
| Vestal Point Capital, LP | Shareholder |
| Brian Piekos | Treasurer |
Date of last update: 10 Jan 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
